Environmental, Social and Governance Progress Report

Overview

The report describes Teva's 2021 ESG progress, including a 12.9% reduction in total Scope 1 and 2 GHG emissions and a 5.0% reduction in total Scope 3 emissions. It highlights four access-to-medicines programs launched for vulnerable populations, alongside 307,610 doses provided through these programs. The report also identifies 37,537 employees and confirms reporting in accordance with GRI and SASB, with limited external assurance by DNV.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: Ends 31 December 2021
Language: English
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services